A ‘blis­ter­ing’ start to M&A in 2023 stokes hopes of a mar­ket re­bound, as in­sid­ers pre­dict a surge in deals

Big drug­mak­ers have start­ed 2023 with their check­books out, sign­ing sev­er­al multi­bil­lion-dol­lar takeovers in what some in­dus­try in­sid­ers see as the start of an M …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER